The Similac or Enfamil products at issue in the litigation are cow’s-milk-based formulas specifically designed for premature infants. However, the formula manufacturers did not warn parents or medical providers that cow’s-milk-based formula carries a substantially increased risk of NEC for premature infants. Parents of affected infants are now suing manufacturers Abbott Laboratories and Mead Johnson for the harm they have caused.
NEC is a serious gastrointestinal disease that is most often seen in premature babies. It causes severe inflammation leading to intestinal tissue damage. In some cases, a hole develops in the infant’s intestinal wall, allowing bacteria to leak into the abdomen. Babies with NEC can become very sick, require major surgery, and develop lifelong complications. Tragically, NEC is often fatal in premature infants.
Multiple studies have shown that the risk of a premature infant developing NEC is significantly higher when fed cow’s-milk-based infant formula. One study found a 77% reduction in the odds of developing NEC for babies receiving an exclusive human milk diet over those fed or fortified with a cow’s-milk-based product. The manufacturers of Similac and Enfamil did not warn consumers of this risk. As a result, innocent babies have suffered by consuming their formula, and families have been torn apart by loss and overwhelming financial burdens.
"*" indicates required fields
02.23.23